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Strengths and limitations of this study
 ► First feasibility trial in the UK to evaluate a new, brief 
but intensive Hybrid CBT for pain- related insomnia 
compared with self- help control in primary care.
 ► The Hybrid CBT was manualised, the delivery of 
which was supported by a comprehensive therapist 
training programme.
 ► Patient recruitment was tested in three different 
health centres of different demographic composi-
tions and different socioeconomic backgrounds.
 ► The mixed- methods approach provided both quan-
titative and qualitative information to inform the de-
sign and planning of a definitive trial.
 ► Rates of attrition and loss to follow- up were high in 
both arms.
AbStrACt
Objectives To test the feasibility of implementing a brief 
but intensive hybrid cognitive behavioural therapy (Hybrid 
CBT) for pain- related insomnia.
Design Mixed- methods, with qualitative process 
evaluation on a two- arm randomised controlled feasibility 
trial.
Setting Primary care.
Participants Twenty- five adult patients with chronic pain 
and insomnia.
Intervention Hybrid CBT or self- help control intervention.
Primary and secondary outcome measures Primary 
outcomes measures were the Insomnia Severity Index 
and interference scale of the Brief Pain Inventory (BPI). 
Secondary outcomes measures were the present pain 
intensity rating from the BPI, Multidimensional Fatigue 
Inventory, Hospital Anxiety and Depression Scale and EQ- 
5D- 5L.
results Fourteen participants were randomised to receive 
Hybrid CBT, 11 to receive the self- help control treatment. 
Of the 14 in the Hybrid CBT group, 9 (64%) completed all 
four treatment sessions (4 discontinued due to poor health; 
1 due to time constraints). Adherence to the self- help 
control treatment was not monitored. The total number 
of participants completing the 12- week and 24- week 
follow- ups were 12 (6 in each group; Hybrid CBT: 43%; 
self- help: 55%) and 10 (5 in each group; Hybrid CBT: 36%; 
self- help: 45%). Based on the data available, candidate 
outcome measures appeared to be sensitive to changes 
associated with interventions. Thematic analysis of pre- 
postintervention interview data revealed satisfaction with 
treatment content among those who completed the Hybrid 
CBT, whereas those in the self- help control treatment 
wanted more contact hours and therapist guidance. Other 
practical suggestions for improvement included shortening 
the duration of each treatment session, reducing the 
amount of assessment paperwork, and minimising the 
burden of sleep and pain monitoring.
Conclusion Important lessons were learnt with regard 
to the infrastructure required to achieve better patient 
adherence and retention. Based on the qualitative 
feedback provided by a subset of treatment completers, 
future trials should also consider lowering the intensity of 
treatment and streamlining the data collection procedure.
trial registration number ISRCTN17294365.
IntrODuCtIOn
Chronic pain is a major burden to primary 
care, accounting for 5 million general prac-
titioner appointments each year in the 
UK.1 2 These pain patients usually present with 
multiple symptoms, with insomnia being one 
of the most common and disruptive comor-
bidities.2–4 In hospital pain clinics, as many 
as 90% of the patients report insomnia of a 
severity that warrants clinical attention.3 5–8
Conventionally sleep disturbance is seen 
as a secondary symptom to pain, but recent 
research has shown that poor sleep is actually 
a key driver for persistent pain and its asso-
ciated distress and disability.9–13 Additionally, 
untreated insomnia is a significant risk factor 
for adverse health outcomes, for example, 
hypertension, cardiovascular disease, obesity, 
diabetes, respiratory diseases and even 
increased mortality.14–20
Although better sleep has long been 
emphasised by pain patients as an important 
treatment outcome,21 22 insomnia is rarely 
a focus in pain management programmes. 
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In primary care where most chronic pain patients are 
managed, hypnotics continue to be first- line treatments 
for insomnia despite the limited evidence supporting 
their long- term efficacy and safety.23 Their prolonged use 
can result in undesirable side effects, increasing the risks 
of falls, road traffic accidents, dementia and mortality in 
the long term, particularly in older adults.24–28 The risks 
multiply when the effect of polypharmacy is factored 
in. The combined use of benzodiazepines and opioids 
produce significant respiratory depression and is thought 
to contribute to the recent sharp rise in unintentional 
prescription drug overdose deaths.29
Psychological interventions offer a promising treatment 
alternative. The efficacy of cognitive behavioural therapy 
for primary insomnia (CBT- I) has been demonstrated 
by multiple systematic reviews and meta- analyses.30–36 
However, these treatments are often not available for 
chronic pain patients because of the lack of an empirically 
validated treatment protocol adapted and tailored for 
this population,37 a shortage of skilled therapists38–40 and 
an absence of essential infrastructure for CBT delivery in 
primary care.28 30 41
We have recently evaluated a talking therapy specifi-
cally modified for patients with pain- related insomnia.42 
The intervention simultaneously tackled chronic pain 
and insomnia, combining select components of CBT- I 
with interventions targeting the cognitive- behavioural 
processes maintaining chronic pain. The Hybrid CBT was 
delivered as an individual therapy over 4 weeks through 
weekly 2- hour sessions. The treatment dosage was 8 hours 
in total, approximating the optimal dose recommended 
for CBT for insomnia disorders43 within a stepped care 
model.39 In our pilot study with patients recruited from 
hospital pain clinics (ie, secondary care), the Hybrid CBT 
was associated with greater improvement in sleep at post- 
treatment compared with a symptom- monitoring control 
procedure (treatment effect size of Hybrid CBT: dH=2.92; 
control: dC=0.56).
42 Pain intensity did not change 
(dH=−0.13; dC=0.14), but the Hybrid CBT was associated 
with greater reductions in pain interference (dH=1.92; 
dC=1.19), fatigue (dH=1.81; dC=0.15) and depression 
(dH=0.94; dC=−0.04) than control.
42
The current study tested the feasibility of adapting and 
implementing the Hybrid CBT in primary care, using a 
mixed- methods approach. With a small patient sample 
across three primary care centres from localities with 
different socio- economic and demographic character-
istics, our overarching aim was to generate information 
to inform the development of a definitive randomised 
controlled trial (RCT) for evaluating the clinical 
outcomes and cost- effectiveness of the Hybrid CBT within 
the UK National Health Service setting. The focus of the 
current study was therefore not on detecting differences 
in outcomes between the Hybrid CBT and the control 
groups, but on evaluating the technical and logistic feasi-
bility of a full- scale study. Specifically, our aims were to: (i) 
check participant’s willingness to be randomised between 
the Hybrid CBT and self- help control intervention, 
(ii) assess recruitment strategies of practices, staff and 
patients, (iii) estimate attrition rates throughout the 
study, (iv) evaluate performance and acceptability of 
candidate outcome measures and (v) evaluate the data 
collection method. Hence, in this article, we report the 
methods and findings from the feasibility trial, along with 
qualitative findings based on our process evaluation of 
patient experience.
MethODS
Patient and public involvement
Two patient representatives with prior training for 
research involvement were recruited for this study 
through the Warwick Universities/User Teaching and 
Research Action Partnership. Our patient and public 
involvement representatives were co- applicants of the 
grant application and members of the project manage-
ment committee. They were involved in most aspects of 
the study including trial design, therapist training, trial 
implementation and results discussion. Additionally, a 
member of our research team with a chronic pain condi-
tion gave significant insights into the running of the trial 
on top of their technical research expertise.
trial setting and design
The feasibility study was a RCT with a multicentre, 
parallel- group design situated within primary care. Treat-
ments were offered to adults living with chronic pain and 
insomnia in the community and delivered by trained 
health psychologists at the primary care centre from 
which the patients were recruited.
Participants were randomly assigned to receive one of 
two trial treatments for pain- related insomnia, in addi-
tion to treatment as usual (TAU). Here, TAU referred 
to the existing advice and prescribed medications for 
pain and insomnia that the participants were receiving. 
The assumption of TAU reflected the clinical reality that 
most patients with these chronic conditions would have 
already received some medical advice or treatment for 
their symptoms.
treatments
Hybrid CBT
The Hybrid CBT comprised select components of 
CBT- I and interventions designed to target cognitive- 
behavioural processes maintaining chronic pain. The 
core components of the treatment were described by 
Tang et al42 and included sleep psychoeducation, stim-
ulus control therapy, sleep restriction therapy and cogni-
tive therapy for addressing insomnia- related cognitions 
and behaviours common among patients with chronic 
pain. It also included individual formulation, goal setting 
and behavioural activation, components for reducing 
pain catastrophising and safety- seeking behaviour and 
reversing mental defeat for the management of chronic 
pain. The treatment was manualised for this study to facil-
itate therapist training; the guiding treatment principles 
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were laid out in the treatment manual to support flexible 
treatment delivery for this patient group with complex 
needs.
The format of the treatment can be described as ‘brief, 
intensive and concentrated’.44 Each patient allocated to 
the Hybrid CBT group was offered a total of four indi-
vidual sessions on a weekly basis. Each session was approx-
imately 2 hours long. The idea was to maintain the level of 
treatment content while minimising the burden of travel 
and duration of treatment, which may hinder treatment 
engagement in this patient group.45
Self-help control treatment
Existing patient reading materials were amalgamated 
(with minimal modification) into four booklets to 
provide a self- help treatment on managing chronic pain 
and insomnia. The materials on insomnia were collated 
from the self- help treatment developed by Morgan et al.46 
Compared with TAU, the use of these self- help materials 
was found to be effective in improving insomnia symptoms 
in older adults attending primary care for sleep and other 
comorbid chronic conditions (post- treatment effect size 
on sleep measures ranged from d=0.69 to 0.7).46 The self- 
help booklets were posted to the patients’ homes, one at 
a time on a weekly basis. The content of the self- help gave 
equal coverage on chronic pain and insomnia manage-
ment, approximating the structure and content of the 
Hybrid CBT. The self- help control treatment represented 
an active treatment control minus therapist contact.
therapists
In the UK, clinical psychologists are not usually a part 
of the primary care medical team. Patients are often 
referred to see a psychologist for psychological interven-
tions on an as- needed basis. Other provisions of care exist, 
for example, in- house counsellors and local Improving 
Access to Psychological Therapy teams, but availability of 
these services varies depending on locality and resource 
allocation. Previous trials of CBT- I in primary care have 
recruited nurse/health visitors for the delivery of treat-
ment.47 Given the content (ie, treatment of two complex 
health conditions), approach (non- protocol- based 
CBT), format (individual, brief but intensive) and focus 
(behaviour change) of the Hybrid CBT, health psycholo-
gists were chosen as therapists for this trial.
Following targeted recruitment via health psychology 
training centres and professional networks across the UK, 
six health psychologists—fully qualified or in the latter 
stages of their stage II doctorate—were selected to receive 
3 days of intensive training offered by the team. Three 
withdrew before the trial commenced due to clashes with 
existing employment/study commitments (eg, main-
taining private practice and completing other training) 
and the distance of travelling involved in the process of 
treatment delivery (eg, from London or Staffordshire, 
where the recruited therapists were based, to Coventry, 
Rugby and Warwickshire, where the primary care centres 
were located). The remaining three (100% female) went 
on to become the trial’s therapists, which involved further 
training at their own pace via learning resources posted 
online, case piloting, regular individual supervision by 
experienced health psychologists on the team (HKS, SP, 
NKYT) and travelling across sites to offer treatment to the 
patients in their localities.
Patients
We recruited 25 people living with chronic pain, between 
April 2016 and April 2017 from three primary care 
centres in Coventry/Warwickshire of different demo-
graphic compositions (respectively having 2.1%, 3.7% 
and 25.8% non- white population) and different socioeco-
nomic backgrounds (respectively scoring 1, 5 and 8 on 
the 1–10 Index of Multiple Deprivation).48
We identified participants for the study from the elec-
tronic registers held by the participating centres. Patients 
were initially screened by searching each centre’s elec-
tronic patient records for inclusion criteria. We did two 
searches, with search terms broadened to include specific 
medications for the second search.
Inclusion criteria were individuals (i) aged 18 years or 
above, (ii) English- speaking, (iii) registered with one of 
the participating centres, (iv) with a history of chronic 
pain and insomnia (as indicated by their medical records), 
with (v) pain of at least moderate severity (>4/10 on a 
present pain intensity numerical rating scale for at least 6 
months) and (vi) clinical insomnia (>15 on the Insomnia 
Severity Index (ISI), >3 nights a week, >1 month in dura-
tion). Criteria (vi) mapped onto the American Academy 
of Sleep Medicine Research Diagnostic Criteria for 
Insomnia Disorder,49 which is consistent with the Diag-
nostic and Statistical Manual of Mental Disorders-5 diag-
nostic criteria, although the latter adopted a 3- month 
duration criteria.50
Participants taking pain/sleep medications on a stable 
regimen were included if they met criteria of the study. 
However, we excluded potential participants with diag-
nosed or suspected medical/psychiatric/sleep disorders 
for which CBT- I was contraindicated as first- line treatment 
or those who had recently enrolled in or were completing 
a pain management programme, or other psychological 
treatments for pain or sleep.
As this was a feasibility study, no formal power calcu-
lation to test the effectiveness of the intervention was 
possible. The current sample size was determined by 
practicalities and considerations that it was sufficiently 
large to ensure that randomisation was acceptable and to 
buffer against atypical attrition.
A randomisation list was created by the trial statisti-
cian (HP) using random blocks of varying sizes (block 
length=4 or 6). Blocks were generated in groups of 
patients at a 1:1 ratio, and stratified by centre from which 
the participants were recruited. Patients were randomised 
sequentially as they became eligible for inclusion in 
the study. Allocation was concealed using ‘e- envelopes’, 
which were macro- enabled MS Excel files preserved as 
read- only with automatic saving on any alteration to the 
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box 1 Seed questions used in the semi- structured 
interviews pre- intervention and postintervention for both 
hybrid Cbt group and self- help control group arms.
A. Pre- intervention interview
1. We are very interested in your journey. When did you first notice 
your pain- related sleep disturbance?
2. Did you put it down to anything?
3. Did you talk to anyone about it?
4. What did you do to try to help?
5. Does anything make it better or worse?
6. Have you seen any health professionals or other practitioners?
7. What do you think is going to happen in this study?
8. What are you hoping to get from this study?
B. Postintervention interview
1. How did you get on with the study?
2. Did you get any benefit from the study (attending the sessions/
receiving the booklets)?
3. What worked for you?
4. What did not work for you?
5. Would you recommend this type of programme to other people?
6. If we ran this programme in a larger study is there anything you 
would change?
7. How did you get on with the paperwork?
8. How did you find the process of being in a research study?
file to give an audit log. This method was considered cost- 
efficient for a small- scale feasibility study. Furthermore, 
the study statistician only released these e- envelopes and 
their passwords in small batches on request by the trial 
coordinator (CM). The study statistician had no contact 
with participants at any point in the study.
Quantitative outcome measures
We piloted the use of five validated questionnaires to 
collect data in this population. Our candidate primary 
outcomes were the ISI51 and Brief Pain Inventory (BPI) 
pain interference subscale.52 Candidate secondary 
outcomes included the present pain intensity rating from 
the BPI,52 Multidimensional Fatigue Inventory general 
fatigue score,53 Hospital Anxiety and Depression Scale54 
and EuroQoL EQ- 5D- 5L,55 for which health utilities were 
calculated using the UK tariff of the EQ- 5D- 5L value set.56 
The health thermometer score was also reported.
Several process measures were included as part of the 
assessment to inform treatment and elucidate the role 
of hypothesised treatment mechanisms. These were the 
Pain Catastrophizing Scale,57 Pain Self Perception Scale,58 
Anxiety and Preoccupation about Sleep Questionnaire,59 
Dysfunctional Belief and Attitude about Sleep Scale-1660 
and Pain- specific Dysfunctional Belief and Attitude about 
Sleep Scale.61
In addition, the participants were asked to complete 
a daily sleep diary modified from the Consensus Sleep 
Diary62 and to wear an actigraph (Model: MW8, supplied 
by CamNTech) for a week for baseline and 12- week 
follow- up assessments to examine the feasibility of incor-
porating objective sleep measures for future trials.
Statistical analysis
As the aim of the current trial was to evaluate study 
feasibility, not treatment efficacy, no formal between- 
group analyses were planned. However, planned anal-
yses consisted of the generation of descriptive statistics 
for all time points, across all participants as a group, and 
the Cronbach’s alpha of the candidate primary outcome 
measures to assess if internal consistency of these 
measures was adequate when administered in a chronic 
pain patient sample with a minor modification (ie, the 
sleep item was removed from the BPI to avoid crite-
rion contamination). The candidate primary outcome 
measures were also checked for correlation to establish if 
co- primary outcomes were needed for a definitive study.
Qualitative participant interviews
Face- to- face semi- structured interviews were conducted 
before and after the intervention to explore participants’ 
expectations of the intervention and their overall expe-
rience postintervention. These interviews were carried 
out individually with a subgroup (20%) of participants 
enrolled in the trial by a Research Fellow who specialises 
in qualitative health service research but was not involved 
in the treatment design and delivery process (VPN). The 
interviewer had no prior contact with the interviewees. 
Seed questions used to prompt these conversations are 
shown in box 1.
Timelines of the participant’s symptom and treatment 
journey were drawn during the interview and field notes 
were written immediately postinterview to promote 
reflexivity. The interviews were held at the participant’s 
primary care centre, and lasted for about 60 min each. 
Interviews were audio- recorded on an encrypted digital 
device. Recordings were transcribed verbatim and anony-
mised. Data transcription was supported by another 
doctoral- level Research Fellow with experience in quali-
tative healthcare research but again not involved in the 
study design and treatment delivery process (VEJC). 
NVivo software was used for managing the data for anal-
ysis of the interview transcripts.
Thematic analysis was performed on the transcripts by 
the principal investigator (NKYT) following the six key 
processes recommended by Braun and Clarke63; famil-
iarisation with the data set, generating initial codes, 
searching for themes, reviewing themes, defining and 
naming themes and report production. Codes and 
themes extracted were then reviewed by the interviewer 
(VPN) and a second experienced qualitative researcher 
on the team (DRE) to check for accuracy. Comments 
received were then used to revise the analysis. Themes 
were extracted with the awareness that questions asked 
in the pre- intervention interviews were different from 
the postintervention interview, and hence the anal-
ysis avoided referring to any within- participant change 
across these interviews. Constant comparisons were 
applied when analysing the postintervention interviews, 
contrasting the experience of the participants assigned to 
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receive Hybrid CBT with those assigned to the self- help 
control treatment.
reSultS
Search results
The searches identified a total of 1434 potentially eligible 
patients across the three primary care centres (9.8% of 
all records). After receiving an invitation to become part 
of the study, 85 patients responded and were invited to 
telephone (n=45) and then in- person (n=40) screening 
to be further assessed for eligibility. Of the 25 (55.6% of 
screened) participants who were found to be eligible, 
all were recruited into the study. This corresponded to 
a pick- up rate of 1.7 per 1000 registered patients and a 
successful recruitment rate of 1.9 participants per month, 
or 0.6 participants per centre per month. Figure 1 spec-
ifies the number and reasons for exclusion at screening 
and subsequent stages.
baseline participant characteristics
Table 1 summarises the sociodemographic details 
provided by the study participants at baseline (n=25). At 
the group level, 56% of the participants were female with 
an average age of 49 years and a mean body mass index 
of 29. The majority of the participants were white (96%) 
and married or living as married (60%). Forty- four per 
cent of the participants had secondary level education 
as their highest educational qualification. At the time 
of the study, 40% of the participants were in paid work 
while 60% were unemployed, retired or engaged in other 
forms of activity, with 36% receiving some form of social 
benefits.
The mean reported duration of pain was 11 years. Most 
of the participants described their pain as ‘constant’ and 
the median number of pain sites reported was 5, with 
lower back as the most commonly identified pain site, 
followed by neck, shoulders, joints, legs, knees, arms, 
upper back, head and abdomen. The baseline present 
pain intensity VAS was 6.1, pain interference score was 
6.6 and ISI was 18.9.
treatment adherence and attrition
All 14 participants assigned to the Hybrid CBT group 
completed session 1, 9 completed (64.3%) sessions 
2, 3 and 4. Of the five participants who discontinued, 
four gave ‘poor’ health and one gave ‘lack of time’ as 
reasons for withdrawal (figure 1). Those withdrawn were 
recruited from primary care centres with more severe 
deprivation indices. For the self- help control group, all 
leaflets were mailed to the participants weekly, as per 
protocol. No further adherence data were collected. At 
12 weeks, six participants were successfully followed up 
in each arm and at 24 weeks, five. This gave an overall 
participant retention rate of 48% at 12 weeks and 36% 
at 24 weeks.
Outcome measures
Both primary outcome measures appeared to have excel-
lent internal consistency. The Cronbach’s alpha for the 
cohort was 0.94 (95% CI 0.92 to 0.97) for the ISI and 
0.88 (95% CI 0.87 to 0.95) for the pain interference 
score. Even though the BPI sleep item was dropped to 
avoid criterion contamination, there was a strong non- 
zero correlation between ISI and BPI interference score 
(r=0.81, 95% CI 0.67 to 0.89).
Descriptive statistics of all primary and secondary 
outcome measures, as well as process measures, by assess-
ment time points, are shown in table 2. No adverse events 
were reported in either allocation groups.
Participant interviews
Five patients were interviewed; three were from the 
Hybrid CBT group and two were from the self- help 
control group. All completed both pre- intervention and 
postintervention interviews, except one in the Hybrid 
CBT group who only completed the pre- intervention 
interview.
Pre-intervention
Discussions in the pre- intervention interviews gave rise 
to six interesting themes, capturing several prominent 
psychosocial characteristics of the participants enrolled 
in the feasibility study. These themes (presented in table 3 
with additional illustrative quotes) were concerned with 
the participants’ sense of identity, personal adversities, 
treatment experience and coping strategies, perceived 
pain- sleep relationship, satisfaction with current service 
and treatment expectations.
Pain changed who I am
There was a sense of damaged identity shared across the 
five participants interviewed. They appeared to define 
themselves by their experience of pain and losses due to 
pain. Frequent comparisons were made of what life was in 
the past, with what life is now and what life should be like 
at a certain age. The way in which participants spoke of 
their struggle with pain carried a sense of mental defeat.
I’ve been suffering with sleep deprivation for many 
years…pain the same. … it destroyed everything re-
ally… life changed a hell of a lot, … it stole my life 
away. (Patient C)
Pain and sleep did not occur in psychosocial vacuum
The interviewees’ descriptions of their treatment jour-
neys revealed that the issues of chronic pain and insomnia 
were embedded within a larger context of personal adver-
sities. It was difficult to tell whether these were psycho-
social triggers or consequences of chronic pain and 
insomnia. Specifics of these adversities revealed them-
selves at different places of the interviews, where details 
of personal lives were volunteered to situate the conver-
sation. Adversities came not in isolation but in clusters 
as chronic pain and insomnia became increasingly more 
severe and disabling. Example adversities cited included 
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Figure 1 Consolidated Standards of Reporting Trials flow diagram from screening (open boxes) to postscreening (filled boxes) 
processes in the study. GP, general practitioner; TAU, treatment as usual.
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Table 1 Participants’ characteristics as measured at 
baseline
Baseline variable
All
n=25
Recruitment centre
(n, %)
Primary care centre 
1
8 (32)
Primary care centre 
2
10 (40)
Primary care centre 
3
7 (28)
Gender (n, %) Female 14 (56.0)
Age: years (mean, SD) 49.3 (9.8) *
Body mass index: kg/m2 (mean, SD) 29.3 (7.6)
Ethnicity (n, %) White 24 (96)
Relationship status
(n, %)
Cohabiting/Married/
Engaged
15 (60)
Single/Separating 10 (40)
Education (n, %) No formal 
qualifications
8 (32)
Secondary 11 (44)
Degree/Professional 
qualification
6 (24)
Employment (n, %) Paid work 10 (40)
Retired/Medically 
retired
6 (24)
Unemployed 5 (20)
Other 4 (16)
Receiving benefits?
(n, %)
Yes 9 (36)*
How long have you had the pain?
(minimum, in years) (mean, SD)
11.0 (9.0)†
What the pain is like? 
(n, %)
Constant 20 (80)
Recurrent 3 (12)
Occasional 1 (4)
Missing 1 (4)
No. of painful places given (median, range) 5 (1–8)
Where is the pain?
(n, %)
Head 3 (12)
Neck 17 (68)
Shoulders 18 (68)
Upper back 6 (24)
Lower back 18 (72)
Arms 9 (36)
Legs 15 (60)
Knees 13 (52)
Abdomen 2 (8)
Joints 15 (60)
Other 7 (28)
Brief Pain Inventory 
(mean, SD)
Current pain severity 6.1 (1.5)
Current pain 
interference
6.6 (1.5)
Continued
Baseline variable
All
n=25
Insomnia Severity Index 
(mean, SD)
Total score 20.1 (4.9)
*One participant missing data.
†Three participants missing data.
Table 1 Continued
ill health, mental health problems, car or work accidents, 
assaults, relationship breakdown, problems experienced 
by dependents or close family members, being a carer, job 
redundancy/unemployment, financial difficulties, home-
lessness and bereavement.
Participants were not treatment naïve
Perhaps an artefact of self- selection bias in an RCT, all 
participants interviewed had tried to manage their pain 
and insomnia using a combination of drug and non- drug 
strategies, invariably with limited success. The self- helping 
spirit is a double- edge sword. If the right treatment is 
identified, it could facilitate engagement and maximise 
treatment gains. It could also drive people to take bold 
steps to keep pain and sleep problems under control, 
using strategies that are not necessarily recommended 
by current evidence- based guidelines, which may lead to 
dashed hope and further demoralisation.
…Now I try to keep (pain medication) in my system 
all the time so there’s always something there …rath-
er than waiting for the pain to start and then taking 
(the medication). [Interviewer: Right so have you 
done that on the advice of somebody or off your own 
back?] No just off my own back… (Patient B)
Pain was thought to be the primary cause of sleep problems
All participants interviewed shared a strong belief that 
pain was a major cause of their sleep problems. However, 
there was the awareness that other factors might also play 
a role in aggravating the sleep problems and that not 
sleeping well could have a reciprocal effect on the pain.
[It’s the pain that] keeps me awake…As soon as you 
have pain then wakes…Sometimes you can’t sleep be-
cause of the pain, and then you’re up all night, you 
get yourself angry with yourself… (Patient C)
Participants were dissatisfied with the services available
All participants interviewed have had much interaction 
with multiple health service providers. They were most 
frustrated when they felt they were not being listened to 
or misunderstood by their GPs. They were also not happy 
with a lack of effective treatment choices, noting a contra-
dictory combination of a heavy reliance on drugs for pain 
control with a general reluctance to prescribe sleeping 
tablets for insomnia.
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Table 2 Descriptive statistics of the candidate primary and secondary outcome measures, as well as process measures
Baseline 12 weeks 24 weeks
All
(n=25)
No. of valid 
response (n, %)
All
(n=25)
No. of valid 
response (n, %)
All
(n=25)
No. of valid 
response (n, %)
Primary outcomes
  ISI (mean, SD) 20.2 (4.7) 24 (96) 14.4 (10.3) 10 (40) 14.8 (11.8) 8 (32)
  BPI interference 6.1 (1.7) 24 (96) 4.9 (2.5) 12 (48) 4.7 (2.7) 8 (32)
Secondary outcomes
  BPI—pain intensity 6.2 (1.6) 24 (96) 5.1 (2.4) 12 (48) 5.5 (2.6) 8 (32)
  MFI—general fatigue 16.3 (3.6) 24 (96) 13.8 (3.7) 12 (48) 14.9 (3.2) 8 (32)
  HADS—anxiety 9.7 (3.0) 24 (96) 6.7 (5.5) 12 (48) 8.9 (4.9) 8 (32)
  HADS—depression 8.4 (3.5) 24 (96) 7.3 (4.6) 12 (48) 7.8 (5.1) 8 (32)
  EQ- 5D—health 
thermometer score
50 (17.5) 24 (96) 58.9 (15.2) 12 (48) 58.8 (23.0) 8 (32)
  EQ- 5D—utility score 0.60 (0.19) 24 (96) 0.57 (0.29) 12 (48) 0.56 (0.33) 8 (32)
Process measures
  PCS—pain 
catastrophising
15.7 (9.2) 24 (96) 9.5 (8.5) 12 (48) 10 (8.6) 8 (32)
  PSPS—mental 
defeat
30.8 (23.6) 23 (92) 21.9 (27.3) 12 (48) 14.7 (21) 6 (24)
  APSQ—sleep anxiety 68 (21.7) 24 (96) 50.2 (32.4) 12 (48) 49.2 (37) 9 (36)
  DBAS—sleep beliefs 5.6 (2.1) 21 (84) 4.1 (2.9) 10 (40) 4.0 (3.3) 8 (32)
  PBAS—pain- related 
sleep beliefs
7.1 (2.1) 21 (84) 5.1 (3.4) 12 (48) 5.0 (3.7) 9 (36)
APSQ, Anxiety and Preoccupation about Sleep Questionnaire; BPI, Brief Pain Inventory; DBAS, Dysfunctional Beliefs and Attitudes and Sleep 
Scale; EQ- 5D, EuroQol EQ- 5D- 5L; HADS, Hospital Anxiety and Depression Scale; ISI, Insomnia Severity Index; MFI, Multidimensional Fatigue 
Inventory; PBAS, Pain- related Dysfunctional Beliefs and Attitudes about Sleep Scale; PCS, Pain Catastrophizing Scale; PSPS, Pain Self 
Perception Scale.
I kept going with all these pain problems and that, 
never get nowhere… Just felt as though it was all in 
my head, nobody would listen to me… (Patient A)
Participants’ treatment expectations were high
All participants interviewed showed understanding that 
the interventions offered were not ‘magic cures’, but 
nonetheless had high expectations for the treatments, 
reflecting the constant tension between ideally what the 
patients want (‘no pain’ and ‘lots of sleep’) and realisti-
cally what can be offered by an intervention designed to 
optimise management of these problems.
Obviously it’s not going to be magical overnight but 
even if it could give me ideas if I’m in that position 
how I should be reacting …. Well my future…hope-
fully I will have no pain … lots of sleep and no stress. 
(Patient D)
These themes, together, contextualised the feasibility 
study, offering finer insights into the life circumstances 
of those who actually signed up for pain- related insomnia 
treatment.
Postintervention
Discussions in postintervention interviews revealed 
aspects of the intervention liked and disliked by the two 
interviewees (as graphically summarised for the Hybrid 
CBT in figure 2). Analysis of these factors was carried out 
separately for the Hybrid CBT and the self- help control 
groups, to generate clear suggestions as to how each of 
these interventions could be tweaked and improved from 
the patient experience perspective.
hybrid Cbt
Besides ‘very good practical advice’ on sleep, both inter-
viewees who completed the Hybrid CBT appeared to most 
appreciate the intervention for giving them a new under-
standing of sleep as well as themselves. In particular, they 
seemed to like the fact that these new insights enabled 
them to improve their sleep patterns and to change the 
way they think about and react to situations in life. Their 
success in improving sleep also appeared to have boosted 
their confidence in initiating changes in other areas of 
their lives; a spill- over therapeutic effect.
… You know, understanding how you sleep really… a 
lot better frame of mind now and a lot better myself 
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Table 3 A summary of findings from the pre- intervention interviews, with additional quotes and implications for future trial 
planning
Theme Additional example quotes and/or notes* Implications for future trial planning
Pain changed who I am “…you’re in pain the whole time… (you) can’t 
move and somebody’s got to help you out of 
bed, which really at 48 I shouldn’t be like that. … I 
feel I’m always going to be a person with pain…” 
(Patient D)
“I like to think that I’m quite strong but equally I 
feel that…I’ve given up. I’m frustrated (because) 
I’m hurting. I can’t escape”. (Patient E)
Patients’ damaged sense of identity—and the 
related psychological processes that feed into 
it—should be kept as a core target of the hybrid 
treatment and measured for pre- post intervention 
changes.
Pain and sleep did not occur in 
psychosocial vacuum
No one single quote could satisfactorily illustrate 
the complexity of the psychosocial contexts 
described by the participants, and without risks of 
revealing their identities.*
Example adversities cited included ill health, 
mental health problems, car or work accidents, 
assaults, relationship breakdown, problems 
experienced by dependents or close family 
members, being a carer, job redundancy/ 
unemployment, financial difficulties, 
homelessness, and bereavement.
While the current hybrid treatment has room to 
support flexible treatment delivery for patients 
with complex needs, more considerations should 
be given to the context in which the treatment is 
being delivered, as well as to practical support 
required to enable the most disadvantaged/
burdened patients to access treatment.
Participants were not treatment naïve “You just try to help yourself a little bit but, 
whether that’s a good or bad thing I don’t know”. 
(Patient A)
“I’m trying to think myself healthy…I’ve tried …
books … having your room right and spraying 
your pillow … all sorts of things…” (Patient D)
“…there wasn’t nothing that I haven’t already 
seen or read or something before….” (Patient E)
Self- help treatments may not be considered 
as a satisfactory treatment option by this non- 
treatment naïve clinical population.
An active alternative treatment with therapist 
contact may be a more appropriate control 
intervention in future trials.
Pain was thought to be the primary 
cause of sleep problems
“I’m not just gonna blame the pain…I’ve got a 
(teenage) son who’s causing … I’m not naïve to 
think that’s not a contributing factor (to sleep 
problems)… And I do stress … that’s just in my 
nature”. (Patient D)
“(when) I wasn’t sleeping the pain seemed more 
unbearable… Unbearable, (because) I was 
tired… And I felt run down it just seemed worse I 
think…” (Patient E)
If patients hold a rigid belief that sleep will never 
improve unless pain is resolved, it would be 
difficult to get their buy- in to the Hybrid CBT 
on offer. As such, these beliefs need to be 
addressed upfront in the information sheet or 
during recruitment, to improve treatment uptake 
and subsequent adherence.
Participants were dissatisfied with the 
services available
  “Most doctors these days don’t…give the time 
of day. They’ve got your prescription written out 
before you go in”. (Patient C)
  “(Interviewer: So have you talked to anybody 
about your pain and sleep?) Only my GP…And 
they sort of got painkillers. They don’t really like 
to give sleeping tablets anymore. Um… They 
advised over the counter ones…which work to 
an extent …” (Patient B)
  “I don’t feel that this surgery offers a lot of (non- 
drug treatments)…it can give (medication), but 
obviously I’ve stopped taking all tablets now for 
5 weeks and I can’t see if there’s a difference 
from taking tablets to the placebo effect of fear 
that at least by reaching for the tablet there was 
something to help me”. (Patient E)
The issue of validation (or the lack thereof) 
is not unique to chronic pain patients, but 
highlights the importance for future trials to 
provide generic clinical skills training to the study 
therapists (health psychologists in the current 
study, or other suitably trained allied healthcare 
professionals with appropriate expertise in future 
trials). This will allow the provision of quality 
therapist contact, which is valued by our target 
patient group.
Participants’ treatment expectations 
were high
“…just to help control pain and sleeping…you 
can’t work miracles but it might be something 
that can help me…To be honest … I’m hoping … 
you might have the magic cure, you never know”. 
(Patient A)
“A bit more sleep. More than anything. I find if 
I’m tired, … the pain seems worse or I’m just not 
able to cope with it as well…So my theory is if I 
can just get a bit more sleep I can perhaps cope 
better with the pain”. (Patient B)
Proactive management of patients’ treatment 
expectations at the outset of treatment, or as 
early as the enrolment stage in future trials, 
may help minimise attrition and unnecessary 
demoralisation.
*Additional notes.
CBT, cognitive behavioural therapy.
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Figure 2 A summary of themes from postintervention 
interviews of Hybrid CBT participants, highlighting the 
positives and negatives of the current treatment approach 
and content. CBT, cognitive behavioural therapy.
you know what I mean? …Because they’re slowly dis-
persing these worries, and things like that, a lot to 
look forward to, and different things, more positive 
now… (It) changes the way you think a little bit and 
me talking to (the therapist) that I want to walk more 
and do more… It makes you think like… I can do 
something about it, I’ve done this, I’ve done um this 
sleep pattern and that… (Patient A)
I'm remembering everything and I really liked the 
study ‘cause it helps me do things different… it’s 
all about retrain(ing) your brain to you know un-
derstand our sleep patterns and things we do in our 
life, what we do and it works, it really really works… 
(Patient C)
Both participants interviewed were also very posi-
tive about the one- to- one, face- to- face interaction they 
had with the therapists. They felt that they were being 
listened to, and really appreciated the fact that the ther-
apists went to the community to offer the intervention 
in their locality. They also felt that they managed to 
derive a greater understanding of the treatment materials 
because they could talk to someone and ask questions as 
they arose, compared with reading the information on 
their own. Furthermore, they felt that being able to talk 
confidentially to someone knowledgeable about their 
symptoms and experience had allowed them to process 
difficult emotions that may or may not be directly linked 
to the experience of chronic pain.
…the one- to- one sessions are good… They are really 
good. Um I don’t know how it would work in a group. 
(Patient C)
…I think you understand it a bit more by talking (to) 
somebody (Patient A)
… I’d go home have a good read about [the treat-
ment materials], some of it I didn’t understand but 
then when I come back I’d ask… or she’d explain to 
me… write it down and show me that this is the way 
to do it… So I was learning a new skill… I don’t think 
I’d have took it so serious … I don’t think I would’ve, 
just read a couple of leaflets and oh yeah and then 
popped it down the side, I wouldn’t have thought 
about it… (Patient C)
… they could come to me and I didn’t have to get 
there. I wouldn’t have done that you see?… Cause it’s 
on your door step it’s a lot easier … and you fit it in 
(Patient A)
Three issues of the Hybrid CBT required attention. 
First, although sleep monitoring was an essential compo-
nent of the intervention, the participants interviewed 
found completing the sleep diary tedious and possibly 
sleep- interfering as they felt obliged to clock their activi-
ties and remember everything they had done. Second, the 
participants found components of the sleep restriction 
and stimulus control therapy hard to follow. Although 
their sleep became more consolidated as a result of these 
treatment components, they did not particularly enjoy the 
experience and felt it was important to be able to person-
alise the intervention. Third, the participants struggled 
to apply the sleep restriction therapy during pain flare 
ups. Further adjustments to the pace and method of the 
therapy may be required considering that an increase in 
pain is a possible side effect during the initial stage of the 
sleep restriction therapy. Application of digital technology 
may also help reduce the burden of data collection.
[The monitoring/diary] was a bit monotonous, but 
then they’re not going to know unless you write it 
down… (Patient A)
I didn’t like that side of it (the sleep restriction and 
stimulus control therapy) ‘cause I do like to stay in 
bed… (Patient C)
…but then you can have a flare up and then you’re 
struggling…you know? (Patient A)
… I was following it all um you know we’ve come 
to like an agreement on timing to go to sleep and 
timing to get up…, but the problem is I’ve got a bad 
neck…It’s really sore and moving it sometimes I can’t 
move it … Can’t go out, can’t drive, can’t do anything 
cause my necks playing me up, so it knocked my sleep 
pattern a bit out of proportion… (Patient C)
Self-help control
The self- help control intervention was chosen to repre-
sent what was the best treatment option available for 
patients with chronic pain and insomnia in primary 
care. However, few positives were said about the self- help 
control intervention, except that the advice given was 
‘sound’ and ‘clear’. While both participants interviewed 
felt that overall the intervention was helpful, they felt that 
they were not learning much new information and could 
not pinpoint any specifics as to why and how the inter-
vention was helpful. Their memories of what was being 
discussed in the self- help booklets were also very vague. 
They felt that the information provided in the booklets 
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overlapped with information available in existing self- 
help books or internet sources. They also indicated that 
they wanted more contacts with healthcare professionals 
rather than being left to their own devices.
‘Yeah the study itself is alright…’… ‘On the sleep 
(side), the things it gives are clear and can be helpful, 
but to me I already practiced those things anyway… 
but I’ve already read up on lots of things and done, 
so there wasn’t a lot there that was explaining that 
I could take away and thought I’ve absorbed some-
thing new’. (Patient E)
So something’s obviously helped along the way but I 
can’t put my finger on one exact thing. [Interviewer: 
is there anything, is there anyway we could improve 
it do you think?] In a way perhaps a bit more contact 
because obviously you have the initial study … I saw 
you for that interview sort of in the middle … And 
then now, but other than the booklets then you are 
just sort of left to it… There’s no contact whatsoev-
er… So some contact would’ve been useful. (Patient 
B)
Other feedback from participants assigned to both 
groups were concerned with the randomisation proce-
dure, intervention format and data collection method. 
On randomisation, the participants in the self- help 
control group indicated that it ‘would have been nice to 
have a choice’, whereas those in the Hybrid CBT group 
imagined that they ‘would not have bothered’ with the 
treatment or would have benefited less had they been 
assigned to the self- help control group. There was also 
an agreement from participants of both groups on the 
intensity of the treatment, with too much to read and/or 
report. While they did not have an issue with automated 
data collection devices (ie, actigraphy), they had found it 
difficult to complete the sleep diary and recommended 
that the paper work of the treatment/study to be reduced.
DISCuSSIOn
Delivering a brief but intensive intervention for the self- 
management of chronic pain and insomnia in primary 
care has proved to be challenging. Important lessons were 
learnt with regard to the infrastructure and trial design 
required to achieve better patient recruitment, treatment 
delivery, intervention adherence and patient retention.
Were the patient identification and recruitment strategies 
viable?
Two searches were conducted to identify potential partici-
pants from electronic records. The initial search that used 
diagnoses as search terms identified only 263 potential 
participants across the three participating centres despite 
the high prevalence rates of both health conditions.64–67 
The unusually low return might be explained by the fact 
that physician records did not always list sleep or chronic 
pain as diagnoses. A second search using a broadened set 
of search terms (including medication prescribed) was 
more successful, identifying 1434 potential participants 
(inclusive of the 263 previously identified). Of those 
who responded to the invitations and were invited to full 
screening, nearly a third were randomised into the study 
(63%). Of those who were not randomised, approximately 
equal numbers were ineligible and declined to attend 
full screening. This indicates that once found, recruiting 
patients into the study may not be an issue for a larger 
study, but capturing interested patients in the first place 
would be a challenge. While the current pick- up rate of 
1.7 per 1000 patients was satisfactory, future trials should 
multiply the number of recruiting primary care centres 
to ensure that the recruitment target will be reached in a 
timely fashion.
Previous research has found that patients with insomnia 
tend to trivialise their symptoms and did not seek treat-
ment due to beliefs that one should be able to cope with 
insomnia alone.68 Despite the brief but intensive nature 
of the Hybrid CBT, 4 weekly sessions plus homework and 
data collection is a significant time commitment. Future 
trials should consider addressing these unhelpful beliefs 
during patient recruitment and incorporate an incentive 
system to motivate eligible participants to commit them-
selves to treatment. For example, a US trial of a 6 weekly 
90 min group CBT for insomnia and pain among older 
adults with osteoarthritis offered a USD$2 cash incentive 
in the initial postal invitation.69 Participants in this study 
were paid volunteers. They received a USD$50 incentive 
payment after completing the baseline assessment and 
attending the first class.69 Similarly, an ongoing nurse- led 
brief insomnia treatment trial in the UK reimburses all 
participants after each completed follow- up visit; £5 at 
baseline, £10 at 3 months, £15 at 6 months and £10 at 
12 months.70 The current study offered the treatment for 
free but did not have the budget to incentivise enrolment 
and treatment attendance.
What were the rates of attrition?
Loss to follow- up was high in this feasibility study, but 
return rates were generally higher in the Hybrid CBT 
group than the self- help control group. Adherence to the 
Hybrid CBT appeared to be most vulnerable after session 
1. Ill health was cited as the main reason for drop- out and 
incidentally, all patients withdrawn were recruited from 
centres with more severe deprivation indices. Those who 
managed to return to session two fully adhered to the 
rest of the treatment programme and appeared to report 
sizeable improvements across outcome measures. Future 
trials should seek to investigate whether any systematic 
attrition from the Hybrid CBT occurs following session 1 
compared with the control intervention, and if so, why? 
One size does not fit all; it would also be important for 
future trials to identify demographic, socioeconomic, and 
clinical factors that predict treatment suitability, directly 
answering the ‘what works for whom’ question.
In addition to a dedicated budget for incentivising 
follow- up rates, practical support (eg, travel reimburse-
ment, appointment reminders, between- session technical 
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support) may also be required to remove participation 
barriers and reduce attrition in future trials. Qualitative 
feedback from our participant interviews also indicates 
that streamlining the data collection with the help of 
digital technologies or the use of a more active control 
intervention with more patient contact may help buffer 
against attrition. Although the Hybrid CBT was generally 
well received by treatment completers, it could be simpli-
fied in future trials to reduce patient burden. We note that 
the majority of the treatment drop- outs coincided with 
the introduction of sleep restriction component of the 
therapy in session 1 and prior to their return to session 
2, when they were expected to report on their progress. 
Considering that sleep restriction is the most difficult 
and counterintuitive component of the therapy to follow, 
future trials with additional support for commencing 
sleep restriction may achieve better adherence to the 
intervention.
how satisfactory and acceptable were the outcome measures 
and data collection methods?
Candidate outcome measures tested in the current trial 
appear to be psychometrically sound and have good face 
validity for the stated purpose of assessment. Both primary 
and secondary outcome measures showed changes in the 
direction anticipated for both arms of the trial over time. 
Care must, however, be taken when interpreting the posi-
tive responses that were reported due to biases associated 
with selective uptake and study attrition. We note that 
participants who remained in the study had lower levels 
of pain intensity at baseline than those who withdrew or 
were lost at the 12- week follow- up (BPI severity: 5.9 vs 
6.4, not tested), although levels of pain interference and 
insomnia were more similar (BPI interference: 6.1 vs 6.2, 
ISI: 20.3 vs 20.1, not tested).
The pattern of change in the outcome measures was 
approximated by those of the process measures that 
assessed the hypothesised maintaining factors of pain and 
insomnia targeted by the treatments. Future trials should 
consider conducting appropriately designed analyses to 
examine whether changes in these processes mediate 
treatment outcomes. The combined use of a sleep diary 
and actigraphy is an important part of the assessment and 
treatment process (not reported in detail here), but the 
implementation of this recommended monitoring proce-
dure proved to be challenging for the participants of the 
current study. Potential solutions to improve monitoring 
adherence in future trials may involve reducing the 
length of the monitoring procedure, more personalised 
data collection training and support and the installation 
of analysis software in participating centres to minimise 
human errors in data transfer.
Strengths and limitations of this study
This was a small- scale feasibility study with a subgroup 
of participants being interviewed pre- post treatment for 
their experience participating in the trial. The specific 
aims were not focused on estimating treatment efficacy 
but on the implementation aspects of the running of 
the trial. We refrained from reporting the data by group 
or estimating effect sizes of treatment as the study was 
neither designed or powered to do so.71 72 Bearing in 
mind the implementation issues discussed above, find-
ings could be used to inform the design of any future 
definitive study but must be interpreted within its bounds 
of generalisability.
Therapist contact and the treatment focus on under-
standing how sleep works were highly valued by our inter-
viewees. The delivery of the Hybrid CBT at the patient’s 
doorstep was also positively received. Future trials should 
seek to maintain the quality of contact, although this will 
have to be supported by a robust health economic anal-
ysis that examines the cost- effectiveness of providing the 
Hybrid CBT in its current format as compared with in 
group settings or in the form of telemedicine or internet- 
based intervention.
While no adverse event was formally reported, qualita-
tive feedback suggested that increased pain—especially 
in the initial treatment period—may be a possible side 
effect of the sleep restriction component of the treat-
ment. Further investigations into the frequency, timing 
and severity of this potential side effect are required to 
ensure patient safety and, potentially, promote treatment 
adherence.
A previous meta- analysis has found the short- term to 
medium- term outcomes of patients with comorbid or 
primary insomnia receiving bibliotherapeutic self- help 
were superior to those of waitlist control.73 Although self- 
help treatment is the best available non- pharmacological 
treatment options in many primary care settings, the trial 
team should consider whether it is an acceptable control 
intervention to offer in future trials. The post- treatment 
interviews revealed that our participants were not naive to 
self- help and appeared to be demoralised by the lack of 
therapist contact and fresh treatment content. Perhaps, 
a therapist- led educational intervention is a more fitting 
control for future trials evaluating the effectiveness of the 
Hybrid CBT in primary care.
COnCluSIOn
The Hybrid CBT has the potential to fill an unmet clinical 
need. Through our feasibility trial, a treatment protocol 
and a corresponding therapist training programme have 
been developed to make the delivery of this brief but 
intensive intervention in primary care possible. In its 
current form, the Hybrid CBT may work for subgroups 
of individuals who manage to adhere to the programme. 
Future trials could overcome the challenges highlighted 
in this feasibility study by broadening recruitment catch-
ment, incorporating an incentive system to motivate 
treatment uptake, streamlining the treatment to make it 
even more primary care friendly and simplifying the data 
collection procedure to make it easier for the patients to 
take part and provide data for evaluation.
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